{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T20:03:31Z","timestamp":1774901011997,"version":"3.50.1"},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T00:00:00Z","timestamp":1351468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1037,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Lab Hematology"],"published-print":{"date-parts":[[2013,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Laboratory diagnosis of von <jats:styled-content style=\"fixed-case\">W<\/jats:styled-content>illebrand disease (<jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content>) requires determination of both von <jats:styled-content style=\"fixed-case\">W<\/jats:styled-content>illebrand factor (<jats:styled-content style=\"fixed-case\">VWF<\/jats:styled-content>) protein levels and activity. Current <jats:styled-content style=\"fixed-case\">VWF<\/jats:styled-content> activity tests include the ristocetin cofactor assay and the collagen\u2010binding assay (<jats:styled-content style=\"fixed-case\">VWF<\/jats:styled-content>:<jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content>). The goal of this investigation is to characterize a new collagen\u2010binding assay and to determine its effectiveness in identifying <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Analytical studies were carried out to characterize the performance of a new <jats:styled-content style=\"fixed-case\">VWF<\/jats:styled-content>:<jats:styled-content style=\"fixed-case\">CB ELISA<\/jats:styled-content>. Additionally, samples from a normal population were tested as were well\u2010characterized type 1 and type 2 <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content> samples.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Repeatability and within\u2010laboratory precision studies resulted in coefficients of variation (<jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>s) of \u226411%. A linear range of 1\u2013354% (0.01\u20133.54\u00a0<jats:styled-content style=\"fixed-case\">IU<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>) was determined, along with a limit of detection and a lower limit of quantitation of 1.6% and 4.0% (0.016 and 0.04\u00a0<jats:styled-content style=\"fixed-case\">IU<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>), respectively. Samples tested from apparently healthy individuals resulted in a normal range of 54\u2013217% (0.54\u20132.17\u00a0<jats:styled-content style=\"fixed-case\">IU<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>). Known <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content> type 1 and type 2 samples were also analyzed by the <jats:styled-content style=\"fixed-case\">ELISA<\/jats:styled-content>, with 99% of samples having <jats:styled-content style=\"fixed-case\">VWF<\/jats:styled-content>:<jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content> below the normal reference range and an estimated 96% sensitivity and 87% specificity using a <jats:styled-content style=\"fixed-case\">VWF<\/jats:styled-content> collagen\u2010binding\/antigen cutoff ratio of 0.50.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This new <jats:styled-content style=\"fixed-case\">VWF<\/jats:styled-content>:<jats:styled-content style=\"fixed-case\">CB ELISA<\/jats:styled-content> provides an accurate measure of collagen\u2010binding activity that aids in the diagnosis and differentiation of type 1 from type 2 <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ijlh.12019","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T16:34:09Z","timestamp":1351528449000},"page":"170-176","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Establishment and characterization of a new and stable collagen\u2010binding assay for the assessment of von <scp>W<\/scp>illebrand factor activity"],"prefix":"10.1111","volume":"35","author":[{"given":"Y.","family":"Ni","sequence":"first","affiliation":[{"name":"Precision BioLogic Dartmouth NS Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nesrallah","sequence":"additional","affiliation":[{"name":"Precision BioLogic Dartmouth NS Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Agnew","sequence":"additional","affiliation":[{"name":"Precision BioLogic Dartmouth NS Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. J.","family":"Geske","sequence":"additional","affiliation":[{"name":"Precision BioLogic Dartmouth NS Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. J.","family":"Favaloro","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pathology and Medical Research Westmead Hospital Westmead NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,10,29]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1281028"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03661.x"},{"key":"e_1_2_7_4_1","first-page":"94","article-title":"von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment","volume":"88","author":"Castaman G","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1054\/blre.1999.0116"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1281031"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03367.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02146.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-947860"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-947865"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e32834a7e01"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1619057"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-27817"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1000364"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03594.x"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02069.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02597.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-06-0360"},{"key":"e_1_2_7_19_1","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1055\/s-0037-1614188","article-title":"Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of Type 2 von Willebrand disease: single center comparison of four different assays","volume":"84","author":"Federici AB","year":"2000","journal-title":"Thromb Haemost"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770100329"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1067\/mlc.2002.127715"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.070730"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03199.x"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.0040s3015.x"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPH5JK4ONENPAE"},{"key":"e_1_2_7_26_1","unstructured":"AdcockDM HoefnerDM Kottke\u2010MarchantK MarlarRA SzamosiDI WarunekDJCollection transport and processing of blood specimens for testing plasma\u2010based coagulation assays and molecular hemostasis assays; approved guideline. H21\u2010A5 Vol. 28 No.5;2008."},{"key":"e_1_2_7_27_1","unstructured":"TholenDW KallnerA KennedyJW KrouwerJS MeierKEvaluation of precision performance of quantitative measurement methods; approved guideline 2nd edn. EP05\u2010A2 Vol. 24 No. 25;2004a."},{"key":"e_1_2_7_28_1","unstructured":"TholenDW LinnetK KondratovichM ArmbrusterDA GarrettPE JonesRL KrollMH LequinRM PankratzTJ ScassellatiGA SchimmelH TsaiJProtocols for determination of limits of detection and limits of quantitation; approved guideline. EP17\u2010A Vol. 24 No. 34;2004b."},{"key":"e_1_2_7_29_1","unstructured":"TholenDW KrollM AstlesJR CaffoAL HappeTM KrouwerJ LaskyFEvaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. EP06\u2010A Vol. 23 No. 16;2003."},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-27815"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208977200"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2002.00683_1.x"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02296.x"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2012.667398"}],"container-title":["International Journal of Laboratory Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijlh.12019","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.12019","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ijlh.12019","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.12019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T11:34:05Z","timestamp":1698665645000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijlh.12019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,29]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.1111\/ijlh.12019"],"URL":"https:\/\/doi.org\/10.1111\/ijlh.12019","archive":["Portico"],"relation":{},"ISSN":["1751-5521","1751-553X"],"issn-type":[{"value":"1751-5521","type":"print"},{"value":"1751-553X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,29]]}}}